Tuesday, February 13, 2024 | 8:30 - 10:00 AM
Main Lecture:
Integrating Delirium and Acute Encephalopathy
Dr. Mark Oldham, University of Rochester
Case Presentation:
A 26 Y/O Male with Gene Therapy Related Delayed Adverse Events CD19/22 CAR-T
Dr. Paul Nyquist, Johns Hopkins University
Date: February 13, 2024
Location: Lipsett Amphitheater / Zoom
Timeline:
8:00 a.m. - Coffee Service
8:30 a.m. - Case Presentation
9:00 a.m. - Main Lecture
Remote Access:
Join via Zoom.gov
Meeting ID: 160 155 6243
Passcode: 348342
One tap mobile
+16692545252 US (San Jose)
+16468287666 US (New York)
Dial by your location
+1 669 254 5252 US (San Jose)
+1 646 828 7666 US (New York)
Meeting ID: 160 155 6243
Note: For attendance purposes, please log-in to your account through https://hopkinscme.cloud-cme.com and link your cell phone number to your profile. If you do not have an existing account, please sign-up using your NIH e-mail.
Activity Description: Through lecture, discussion and slide show this activity will focus on CAR-T Cell Therapy, Delirium and Acute Encephalopathy
Who Should Attend: This activity is intended for Neurologists, Neuroscientists, Neurosurgeons, Neuropsychologists, and Health Care Professionals.
Lecture Specific Educational Objectives:
After attending this activity the participant will demonstrate the ability to:
-
Understand the Diagnosis and treatment of cytokine release syndrome (CRS) and Immune Effector Cell Neurotoxicity (ICANS) in the setting of CAR-T cell therapy.
-
Describe the distinctions and commonalities between delirium and acute encephalopathy.
-
Discuss possible pathophysiological routes to delirium.
-
Apply the model of delirium disorder clinically to address the comprehensive range of potential treatment targets.
Accreditation Statement: This activity has been planned and implemented in accordance with the Essential Areas and polices of the Accreditation Council for Continuing Medical Education through the joint providership of the Johns Hopkins University School of Medicine and the National Institutes of Health (NIH). The Johns Hopkins University School of Medicine is accredited by the ACME to provide continuing medical education for physicians.
Credit Designation Statement: The Johns Hopkins University School of Medicine designates this live activity for 1.5 credits per session for a maximum of 78 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Policy on Speaker and Provider Disclosure: It is the policy of the Johns Hopkins University School of Medicine that the speaker and provider globally disclose conflicts of interest. The Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the instructional materials.